
85.68 BATS BZX Real-Time Price As of 2:06pm ET | ![]() Today’s Change | 71.88 Today|||52-Week Range 108.02 | +0.60% Year-to-Date |
The 23 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 115.00, with a high estimate of 150.00 and a low estimate of 75.00. The median estimate represents a +34.22% increase from the last price of 85.68.
The current consensus among 26 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.